Atsena Therapeutics

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

Adverum Biotechnologies

The company develops ocular gene therapies to treat retinal diseases for patients with vision-threatening conditions such as wet age-related macular degeneration.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Gyroscope Therapeutics

This clinical-stage company develops gene therapies and surgical delivery devices for patients with vision loss caused by geographic atrophy and macular degeneration.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

AAVantgarde

This biotechnology company develops gene therapies for patients with inherited retinal diseases, such as Stargardt disease and Usher syndrome type 1B.

GenSight Biologics

This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.